Nanotherapeutic silibinin: An insight of phytomedicine in healthcare reformation.

Anjali Takke, Pravin Shende

Journal: Nanomedicine : nanotechnology, biology, and medicine 2020;21():102057

PMID: 31340181

Abstract

Most of the herbal origin drugs possess water insoluble active constituents which lower the bioavailability and increase systemic clearance after administration of repeated or higher dose of drug. Silymarin is extracted from the seeds and fruits of milk thistle plant Silybum marianum which consists of main biologically active component as silibinin. However, the clinical applications of silibinin show some limitations due to low aqueous solubility, poor penetration into the epithelial cells of intestine, high metabolism and rapid systemic elimination. But nanotechnology-based drug delivery system explores great potential for phytochemicals to enhance the aqueous solubility and bioavailability of BCS class II and IV drugs, improve stability and modify the pharmacological activity. This review focuses on the therapeutic properties of silibinin and discusses the benefits, challenges and applications of silibinin nanoformulations. Such nanotherapeutic system as a regular medicine will be an attractive approach to reduce the adverse events and toxicities of current therapies.

Copyright © 2019 Elsevier Inc. All rights reserved.

Address: Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management, Mumbai, India.; Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management, Mumbai, India. Electronic address: [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.